基于临床与超声造影特征在高危患者术前识别≤20 mm局灶性肝脏病变中的肝细胞癌
回顾性纳入三个中心386例有肝细胞癌风险且局灶性肝脏病变≤20 mm的患者,基于临床、超声造影及两者联合特征构建预测模型并在内部和外部验证队列评估。联合模型AUC为0.873-0.951,高于临床模型和超声造影模型;改良LI-RADS的LR-5敏感度从83.1%提高到88.9%,特异度无统计学差异。
要点
- 联合临床与超声造影特征的模型在训练、内部及外部验证队列AUC为0.873-0.951,高于临床模型和超声造影模型。
- 改良LI-RADS的LR-5敏感度从83.1%提高到88.9%,特异度无统计学差异(82.6%-94.7% vs 95.7%-97.6%,P=0.162-0.650)。
- 联合模型有助于在高危患者中识别≤20 mm局灶性肝脏病变中的肝细胞癌。
核心结论
- 基于临床与超声造影特征的联合模型有助于在高危患者中识别≤20 mm局灶性肝脏病变中的肝细胞癌。
研究设计与样本
- 回顾性纳入2022年1月至2023年7月三个中心386例有肝细胞癌风险且局灶性肝脏病变≤20 mm的患者(平均年龄58±11岁,277例男性),具备临床及术前超声造影数据。
诊断标准与关键数值
- 联合模型在训练、内部和外部验证队列的AUC为0.873-0.951,高于临床模型(0.749-0.795,均P<0.05)和超声造影模型(0.848-0.899,均P<0.05)。
临床应用与阅片要点
- 采用美国放射学会超声造影肝脏影像报告和数据系统(CEUS LI-RADS)对所有患者重新分类,并与表现最佳的联合模型结合形成改良LI-RADS;改良LI-RADS的LR-5敏感度从83.1%提高到88.9%(P<0.001),特异度无统计学差异(82.6%-94.7% vs 95.7%-97.6%,P=0.162-0.650)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: We aimed to develop and validate a prediction model to identify HCC in focal liver lesions (FLLs) ≤20 mm among patients at risk for HCC based on clinical and contrast-enhanced ultrasound (CEUS) features.
METHODS: Between January 2022 and July 2023, 386 patients (mean age 58 ± 11 years; 277 male) at risk for HCC with FLLs ≤20 mm and clinical and preoperative CEUS data from three centers were retrospectively enrolled. Three prediction models based on clinical data (Cli-M), CEUS features (CEUS-M), and combined clinical and CEUS features (Com-M) were constructed using the training cohort (187 patients). Their predictive performance was evaluated using the area under the receiver operating characteristic curve (AUC), calibration curve, and decision curve analysis (DCA) in the internal and external validation cohorts. All patients were reclassified using the American College of Radiology CEUS Liver Imaging Reporting and Data System (CEUS LI-RADS) and combined with the best-performing model (modified LI-RADS).
RESULTS: The AUCs of Com-M were 0.873-0.951 in the training, internal, and external validation cohorts, which were higher than those of Cli-M (0.749-0.795, all P < 0.05) and CEUS-M (0.848-0.899, all P < 0.05). The sensitivity of LR-5 of modified LI-RADS was significantly improved from 83.1 % to 88.9 % (p<0.001) in the training, internal and external validation cohort while there was no statistical different on its specificity (82.6 %-94.7 % vs 95.7 %-97.6 %., p = 0.162-0.650).
CONCLUSIONS: The model based on clinical and CEUS features can help identify HCC in FLLs ≤ 20 mm in high-risk patients.
引用
- Hu XY, Sun YK, Miao Y, et al. Preoperative identification of hepatocellular carcinoma from focal liver lesions ≤ 20 mm in high-risk patients using clinical and contrast-enhanced ultrasound features. Eur J Radiol. 2025. PMID: 40187198. doi:10.1016/j.ejrad.2025.112076
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。